We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$81B
AUM Growth
-$1.58B
Cap. Flow
-$3.65B
Cap. Flow %
-4.5%
Top 10 Hldgs %
16.13%
Holding
1,955
New
98
Increased
953
Reduced
772
Closed
100

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$786M
2
ABEV icon
Ambev
ABEV
+$368M
3
AAPL icon
Apple
AAPL
+$331M
4
BIDU icon
Baidu
BIDU
+$323M
5
JNJ icon
Johnson & Johnson
JNJ
+$285M

Sector Composition

Rank Sector Weight
1 Energy 15.38%
2 Financials 14.63%
3 Consumer Discretionary 13.36%
4 Healthcare 12.27%
5 Technology 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHC icon
1376
Graham Holdings Company
GHC
$4.97B
$657K ﹤0.01%
1,095
+34
+3% +$20.4K
CSRA
1377
DELISTED
CSRA Inc.
CSRA
$653K ﹤0.01%
20,565
-1,066
-5% -$31.9K
MYGN icon
1378
Myriad Genetics
MYGN
$530M
$651K ﹤0.01%
25,175
-4,996
-17% -$106K
ITT icon
1379
ITT
ITT
$17.5B
$649K ﹤0.01%
16,154
+1,640
+11% +$65.4K
MATV icon
1380
Mativ Holdings
MATV
$448M
$648K ﹤0.01%
17,406
+1,470
+9% +$58.1K
WYNN icon
1381
Wynn Resorts
WYNN
$10.1B
$648K ﹤0.01%
4,835
-333
-6% -$41.9K
ATHN
1382
DELISTED
Athenahealth, Inc.
ATHN
$647K ﹤0.01%
+4,604
New +$575K
TDY icon
1383
Teledyne Technologies
TDY
$30.4B
$644K ﹤0.01%
5,043
+348
+7% +$45.1K
ETD icon
1384
Ethan Allen Interiors
ETD
$581M
$640K ﹤0.01%
19,823
+624
+3% +$18.4K
VRTU
1385
DELISTED
Virtusa Corporation
VRTU
$639K ﹤0.01%
21,729
+2,742
+14% +$80.6K
ALG icon
1386
Alamo Group
ALG
$2.01B
$638K ﹤0.01%
7,015
-1,483
-17% -$124K
NGD
1387
DELISTED
New Gold Inc
NGD
$636K ﹤0.01%
200,000
NUS icon
1388
Nu Skin
NUS
$247M
$633K ﹤0.01%
10,072
-420
-4% -$23.9K
VIAV icon
1389
Viavi Solutions
VIAV
$9.75B
$631K ﹤0.01%
59,945
-7,266
-11% -$78.3K
TNC icon
1390
Tennant Co
TNC
$1.5B
$629K ﹤0.01%
8,525
-127
-1% -$9.21K
CAKE icon
1391
Cheesecake Factory
CAKE
$4.21B
$627K ﹤0.01%
12,469
+2,474
+25% +$146K
ATR icon
1392
AptarGroup
ATR
$8.45B
$626K ﹤0.01%
7,205
-343
-5% -$28.2K
SAFT icon
1393
Safety Insurance
SAFT
$1.52B
$625K ﹤0.01%
9,148
+382
+4% +$26.2K
TDC icon
1394
Teradata
TDC
$2.68B
$625K ﹤0.01%
21,194
+11,715
+124% +$343K
VVC
1395
DELISTED
Vectren Corporation
VVC
$625K ﹤0.01%
10,693
-27
-0.3% -$1.62K
PAHC icon
1396
Phibro Animal Health
PAHC
$1.38B
$624K ﹤0.01%
16,835
-3,939
-19% -$129K
MEI icon
1397
Methode Electronics
MEI
$543M
$623K ﹤0.01%
15,125
+1,302
+9% +$54.3K
MLKN icon
1398
MillerKnoll
MLKN
$1.5B
$621K ﹤0.01%
20,454
+602
+3% +$19.2K
BRCD
1399
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$621K ﹤0.01%
49,286
-74,614
-60% -$940K
BH icon
1400
Biglari Holdings Class B
BH
$1.2B
$620K ﹤0.01%
2,325
-57
-2% -$15.6K

Similar funds

OppenheimerFunds's Q2 2017 Portfolio in Review

As of Q2 2017, OppenheimerFunds held 1,955 positions worth $81B, down 1.9% from $82.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

OppenheimerFunds withdrew a net $3.65B in Q2 2017, closing 100 positions and reducing 772 holdings. Its most notable exit was Energy Transfer Partners L.p., an estimated $786M position sold in full.

By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, OppenheimerFunds opened a new position in Antero Midstream worth $132M.

  • OppenheimerFunds's largest Q2 2017 buy was Antero Midstream: 5,990,120 shares worth $132M.
  • OppenheimerFunds added most to Energy Transfer Partners, L.P. in Q2 2017, an estimated $729M increase.
  • OppenheimerFunds's biggest Q2 2017 reduction was Apple, cutting an estimated $331M.
  • OppenheimerFunds fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $786M.
  • OppenheimerFunds's ten largest holdings make up 16% of its $81B portfolio in Q2 2017.
  • OppenheimerFunds opened 98 new positions and closed 100 in Q2 2017.
  • OppenheimerFunds's portfolio value fell 1.9% quarter-over-quarter to $81B.

Based on OppenheimerFunds's 13F filing for Q2 2017, filed 14 Aug 2017.